Canada backs use of J&J, AstraZeneca virus jabs

Tuesday, 27. April 2021 00:05

The Health Canada and the Public Health Agency of Canada (PHAC) stated on Monday they support the use of Johnson and Johnson's (J&J) and AstraZeneca PLC and Oxford University's vaccines against COVID-19 despite several cases of rare blood clots reported after their application.

"Health Canada continues to consider the benefits of vaccination to outweigh these very rare potential risks, and supports the use of the Janssen and AstraZeneca's vaccines in Canada," the statement read. "We will continue to keep Canadians informed about any safety issues with any COVID-19 vaccines, and will take immediate further action as necessary."

Due to concerns over possible links between those vaccines and the creation of blood clots, Canada's Ontario decided to administer AstaZeneca's jab only to those aged 40 and over. Meanwhile, J&J revealed its study found the company's treatment was 85 % effective against severe cases of the disease.

Related Links: Johnson & JohnsonAstraZeneca plc
Breaking the News / JR